Warnex Announces the Re-Election of Directors and Status of Ongoing Strategic Review

Warnex Inc. (TSX VENTURE:WNX.H)(NEX:WNX) ("Warnex" or the "Company") is pleased
to report that at its annual meeting of shareholders held on June 27, 2013 (the
"Shareholders' Meeting"), each of the current directors of Warnex, namely
Messrs. Michael Singer, Sean Karamchandani and Joseph Walewicz, was re-elected
for another term. Each of the directors received over 93% of the votes cast in
favour of his re-election. Warnex is also pleased to report that at the
Shareholders' Meeting the current auditors of the Company, Nexia Friedman,
Chartered Accountants, were also re-appointed for another term.


Warnex also reports that its Board of Directors continues to evaluate strategic
options for the Company following the closing of the sale of its last
operational division, Bioanalytical Services. "To date, certain opportunities
which have been evaluated have not advanced to completion, while others continue
to form part of our ongoing evaluation process," remarked Michael Singer,
Chairman of the Company. "We will continue to explore the strategic alternatives
available to Warnex, which include, but are not limited to, liquidating the
Company and distributing any remaining assets to shareholders. Further
announcements in this regard will be made as warranted."


Michael Singer further remarked that "as disclosed on May 29, 2013, Warnex's
financial position remains in good health and the significant cost containment
measures completed during the first quarter of 2013 have positioned us to
continue to carefully and thoughtfully evaluate all identified opportunities in
advance of making a final recommendation to shareholders without placing
excessive pressures on our existing working capital. We look forward to reaching
a conclusion and eventual recommendation to Warnex shareholders pursuant to the
ongoing strategic review."


CAUTION REGARDING FORWARD-LOOKING STATEMENTS

Certain statements contained in this news release regarding the ongoing
strategic review and future plans for Warnex are forward-looking and are subject
to numerous risks and uncertainties, known and unknown. In addition to the
various risks and uncertainties set out in the Risk and Uncertainties section of
Warnex's Management's Discussion and Analysis, which can be found under Warnex's
profile at www.sedar.com, the timing, nature and impact of any course of action
that management of Warnex may determine to carry out with respect to the
remaining assets of the Company is uncertain at this time.


Neither NEX nor its Regulation Services Provider (as that term is defined in
policies of the NEX) accepts responsibility for the adequacy or accuracy of this
release.


FOR FURTHER INFORMATION PLEASE CONTACT: 
Michael Singer
Chairman of the Board of Directors
Warnex Inc.
[phone] (ext 311)
[e-mail]